Back to search

Czechia· CZ-9999927

RIFAMPICIN 75MG + ISONIAZID 50MG + PYRAZINAMIDE 150MG

A rifampicin, pyrazinamide and isoniazid product containing rifampicin + pyrazinamide + isoniazid, registered in Czechia. The same ATC class is registered in 6 of our 19 countries.

ATC J04AM05

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedRIFAMPICIN 75MG + ISONIAZID 50MG + PY…ATCJ04AM05REGISTER NO.CZ-9999927PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Rifampicin, pyrazinamide and isoniazid is registered in 6 of 19 countries.

Countries holding a registration under ATC J04AM05 (rifampicin, pyrazinamide and isoniazid), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 4 of them publish a price we can compare per daily dose

Rifampicin, pyrazinamide and isoniazid · ATC J04AM05

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Ireland
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
RIFAMPICIN + PYRAZINAMIDE + ISONIAZID
Manufacturer
—
Country
Czechia (CZ)
ATC code
J04AM05
ATC class
Rifampicin, pyrazinamide and isoniazid
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    9999927
    84
    CZK 1870.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

61 interactions on record for rifampicin, pyrazinamide and isoniazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rifampicin, pyrazinamide and isoniazid · interactions on record

61 records

61 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Rifampicin, pyrazinamide and isoniazid in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin, pyrazinamide and isoniazid products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Spain · Rifater
  • France · Rifater
  • United Kingdom (Northern Ireland) · Rifater
  • Ireland · Rifater
  • Italy · Rifater
  • Norway · Rimcure
  • Portugal · Rifater
  • Sweden · Rimcure
  • Slovenia · Rifater

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a5ea34f0-87db-4dab-9f34-3840aad89f61
GET /v1/drugs/a5ea34f0-87db-4dab-9f34-3840aad89f61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "POR TBL DIS",
  "source": "sukl",
  "strength": "75MG+50MG+150MG",
  "pack_size": "84",
  "substance": "RIFAMPICIN + PYRAZINAMIDE + ISONIAZID",
  "cz_kod_sukl": "9999927",
  "product_type": "CH",
  "substance_codes": "1840,1978,792",
  "registration_state": "I",
  "registration_number": null
}

See everything about rifampicin, pyrazinamide and isoniazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.